Zinc as a phase-specific therapeutic target in hypoglycemia-induced brain injury
{{output}}
Hypoglycemia remains a major cause of neurological morbidity. However, effective targeted therapies for affected brain regions remain lacking. Although excitotoxicity and energy failure have long been implicated, emerging evidence has identified dysregulated z... ...
